Quarterly report [Sections 13 or 15(d)]

Significant Strategic Collaborations (Details Narrative)

v3.26.1
Significant Strategic Collaborations (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 30 Months Ended 39 Months Ended 48 Months Ended
Mar. 02, 2026
Nov. 02, 2025
May 02, 2025
Nov. 02, 2024
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Mar. 17, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Revenue         $ 660,601 $ 589,897 $ 1,467,524 $ 1,183,158          
Prepaid expense and other assets, current         182,311   182,311   $ 182,311 $ 182,311 $ 182,311 $ 166,294  
Accrued expenses and other current liabilities         572,440   572,440   572,440 572,440 572,440 709,916  
Other noncurrent assets         313,921   313,921   313,921 313,921 313,921 313,921  
Research and development expenses         552,013 656,557 1,213,456 1,535,586          
Catalent [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Payment for services                     3,000,000.0    
Prepaid expense and other assets, current         28,000   28,000   28,000 28,000 28,000 28,000  
Accrued expenses and other current liabilities         100,000   100,000   100,000 100,000 100,000 100,000  
Other noncurrent assets         300,000   300,000   300,000 300,000 300,000 300,000  
Scripps Research [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Accrued expenses and other current liabilities         100,000   100,000   100,000 100,000 100,000 200,000  
Contractual obligation                         $ 900,000
Increase in contractual liabilitiy $ 500,000 $ 300,000 $ 400,000 $ 400,000                  
Research and development expenses                   2,400,000      
UVA [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Accrued expenses and other current liabilities         0   0   0 $ 0 $ 0 $ 31,000  
Research and development expenses                 $ 600,000        
Royalty Revenue [Member]                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Revenue         $ 660,601 $ 589,897 $ 1,467,524 $ 1,183,158